These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9925870)

  • 21. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study.
    Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z
    Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome.
    Trevisanuto D; Grazzina N; Ferrarese P; Micaglio M; Verghese C; Zanardo V
    Biol Neonate; 2005; 87(4):217-20. PubMed ID: 15650304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome.
    Berggren E; Liljedahl M; Winbladh B; Andreasson B; Curstedt T; Robertson B; Schollin J
    Acta Paediatr; 2000 Apr; 89(4):460-4. PubMed ID: 10830460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome.
    Duman N; Tüzün F; Sever AH; Arslan MK; İşcan B; Dilek M; Kumral A; Ozkan H
    J Matern Fetal Neonatal Med; 2016; 29(2):252-7. PubMed ID: 25491882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study].
    Verder H; Agertoft L; Albertsen P; Christensen NC; Curstedt T; Ebbesen F; Greisen G; Hobolth N; Holm V; Jacobsen T
    Ugeskr Laeger; 1992 Jul; 154(31):2136-9. PubMed ID: 1509593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: Study protocol for a multi-center prospective randomized controlled trial.
    Zhu XW; Shi Y; Shi LP; Liu L; Xue J; Ramanathan R;
    Trials; 2018 Jun; 19(1):319. PubMed ID: 29898763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early surfactant guided by lamellar body counts on gastric aspirate in very preterm infants.
    Verder H; Ebbesen F; Fenger-Grøn J; Henriksen TB; Andreasson B; Bender L; Bertelsen A; Björklund LJ; Dahl M; Esberg G; Eschen C; Høvring M; Kreft A; Kroner J; Lundberg F; Pedersen P; Reinholdt J; Stanchev H
    Neonatology; 2013; 104(2):116-22. PubMed ID: 23942627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation.
    Dani C; Bertini G; Pezzati M; Cecchi A; Caviglioli C; Rubaltelli FF
    Pediatrics; 2004 Jun; 113(6):e560-3. PubMed ID: 15173537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment].
    Andersen T; Holm HS; Kamper J
    Ugeskr Laeger; 2006 Oct; 168(43):3723-7. PubMed ID: 17069738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation.
    Dargaville PA; Ali SKM; Jackson HD; Williams C; De Paoli AG
    Neonatology; 2018; 113(1):7-14. PubMed ID: 28922658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
    Ramanathan R
    J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early or later prophylactic INSURE in preterm infants of less than 30 weeks' gestation.
    Okulu E; Arsan S; Mungan Akın İ; Alan S; Kılıç A; Atasay B
    Turk J Pediatr; 2015; 57(1):1-8. PubMed ID: 26613214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multicentered Randomized Study on Early versus Rescue Calsurf Administration for the Treatment of Respiratory Distress Syndrome in Preterm Infants.
    Rong Z; Chang L; Cheng H; Wang H; Zhu X; Peng F; Fan Q; Lu W; Pan R; Xiong L; Jiao R; Sun J; Xia S; Xie J
    Am J Perinatol; 2019 Dec; 36(14):1492-1497. PubMed ID: 30716790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants.
    Cherif A; Hachani C; Khrouf N
    Am J Perinatol; 2008 Nov; 25(10):647-52. PubMed ID: 18841536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome.
    Leone F; Trevisanuto D; Cavallin F; Parotto M; Zanardo V
    Minerva Pediatr; 2013 Apr; 65(2):187-92. PubMed ID: 23612264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.